Upcoming scientific meetings endorsed by SOT are featured here.
Society of Toxicology of Canada (STC) 51st Annual Symposium
Ottawa, Ontario, Canada
December 2–4, 2019
Join the STC in Ottawa to explore the theme of “Optimizing testing strategies and exploring novel mechanisms of human and environmental toxicants.” The annual STC symposium gathers toxicologists and risk assessors from government, academia, and industry, along with graduate students and postdoctoral fellows, in a setting that facilitates discussion and collaboration.
Sessions:
- Better models for predicting human toxicity
- Transgenerational effects of exposure to environmental pollutants
- Novel toxicity mechanisms of endocrine-disrupting chemicals
- Assessment of effects of environmental pollutants on humans and other species
This year, we will be celebrating the accomplishments and distinguished career of Jack Uetrecht, MD, PhD, who will be the recipient of 2019 STC Gabriel L. Plaa Award of Distinction. Please join us in this celebration of the science of toxicology. Program details can be found on the STC website. Information on registration, abstracts, and awards is available on the STC 2019 symposium website.
Gordon Research Conference on DNA Damage, Mutation and Cancer
Ventura, California
March 1–6, 2020
The 2020 Gordon Research Conference (GRC) on DNA Damage, Mutation and Cancer is focused on exploring the various sources of DNA damage, how DNA lesions are detected and repaired, and the cellular consequences of repair. This understanding can be exploited to determine vulnerabilities in the repair processes for cancer diagnoses, treatments, and therapies. Of particular interest is the appreciation of the range of mutations that is associated with damage and repair, including the intersection of replication and transcription, the importance of chromosome rearrangements, and the immune response associated with DNA damage and repair. The conference will present new sessions on these topics and aims to consider new approaches and technologies.
For more information, please visit the meeting web page.
American College of Toxicology: Toxicology for Pharmaceutical and Regulatory Scientists
Gaithersburg, Maryland
March 30–April 3, 2020
Don’t miss the much-anticipated American College of Toxicology (ACT) Toxicology for Pharmaceutical and Regulatory Scientists educational course. This annual ACT course provides basic training in general toxicology. Using pharmaceutical development as an example, participants will obtain an overall understanding of the principles of toxicology and nonclinical safety evaluation. The course will include discussion of regulatory case studies and hands-on analyses of nonclinical data. The course is intended to benefit individuals working with small and large molecules from biotechnology and pharmaceutical companies, CROs, and regulatory agencies, or individuals interested in or currently practicing toxicology.
The course will be held from March 30 to April 3, 2020, at the Gaithersburg Marriott Washingtonian Center in Gaithersburg, Maryland. Registration is open on the ACT website. Please do not delay in registering for this course, as space is limited and the course has sold out in the past. If you have any questions, please email ACT Headquarters.
First Integrated International Workshop on Acetyltransferases, Sulfotransferases, and UDP-Glucuronosyltransferases
Louisville, Kentucky
April 1–3, 2020
The First Integrated International Workshop on Acetyltransferases, Sulfotransferases, and UDP-Glucuronosyltransferases is scheduled for April 1–3, 2020, in Louisville, Kentucky, and builds upon the success of past international workshops that focused on a single xenobiotic metabolizing enzyme system. A key purpose and knowledge gap to be met by the integrated workshop is understanding the role of the xenobiotic metabolizing enzymes in environmental health as a group rather than individually. This integration theme was a key rationale for selection of many of the keynote speakers. In an era where powerful genomic technologies are accelerating research into the complex gene‐environment interactions modulating the biological effects of xenobiotics (drugs, carcinogens, etc.), it is critical to include other major families of phase II conjugation enzymes within the context of an integrated workshop. The First Integrated International Workshop on Acetyltransferases, Sulfotransferases, and UDP‐Glucuronosyltransferases will open new channels of interaction and collaboration across a broader scientific community, invigorating the field and expanding its global impact. The workshop will provide important consensus information on the proper use of gene and allelic symbols, as well as conveying recommendations by the HUGO Gene Nomenclature Committee, the PharmacoGenomics KnowledgeBase, the Human Genome Variation Society, etc. The workshop will promote constructive discussion toward harmonization of pharmacogenetic nomenclature and test result reporting for phase II conjugation enzymes, a need recently recognized by an international workgroup of experts led by scientists of the US Centers for Disease Control and Prevention (Clin. Pharmacol. Ther. 2016, 99:172‐85). Abstracts submitted by November 1 will be considered for platform presentations.
For more information, please visit the meeting website.
Gordon Research Conference on Environmental Endocrine Disruptors
Newry, Maine
May 31–June 5, 2020
The 12th Gordon Research Conference (GRC) on Environmental Endocrine Disruptors will be held at the Jordan Hotel and Conference Center at Sunday River in Newry, Maine, from May 31 to June 5, 2020. This 2020 edition of the GRC will be framed around five main topics aimed at providing a comprehensive overview of the latest advances in environmental endocrine disruptor research and involving lectures from leading scientists and rising stars in the field and selected trainee presentations. The conference will cover (1) the latest evidence for the effects of environmental endocrine disruptors on marine and terrestrial environments; (2) the latest evidence on the impacts of environmental endocrine disruptors on human populations; (3) an in-depth review of our current understanding of mechanisms of effects and modes of action of environmental endocrine disruptors, including effects and action at low doses; (4) an updated state-of-the-science on specific issues raised by social, political, and cultural determinants of environmental endocrine disruptor assessment; and (5) the latest scientific findings on emerging exposures, nonclassical environmental endocrine disruptors, and safer alternatives.
For more information, please visit the meeting website.
AHR Symposium 2020: Toxicity to Therapeutics
State College, Pennsylvania
June 14–18, 2020
This meeting will be held in June 2020 and will bring together world-renowned scientists in an integrated program to discuss the latest knowledge on the role of the aromatic hydrocarbon receptor (AHR) in a wide range of fields, from basic immunology to cancer immunotherapy. AHR is recognized as a transcription factor activated by many pollutants, responsible for the induction of xenobiotic metabolism enzymes, and receptor hyperactivation can lead to toxic outcomes, such as tumor promotion. The venue of the conference will be at beautiful Pennsylvania State University in State College, Pennsylvania, and will provide a unique environment for all those who wish to foster/develop collaborative projects and expand their understanding of the complexities of AHR biology.
More information can be found on the meeting website.
